Clinical trial
Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung…
NCT00444223 · Jonsson Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00444223 |
|---|---|
| Title | Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants |
| Official title | The Biodistribution of N-{4-[3'-[F-18] Fluoroethylphenyl)Amino]-6-quinazolinyl}-Acrylamide ([F-F18]FEQA) in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and in Healthy Subjects: A Pilot Study |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Procedure |
| Interventions | fluorine F 18 FEQA + positron emission tomography |
| Enrollment | 3 |
| Start date | May 4, 2004 |
| Primary completion | May 15, 2008 |
| Completion | May 15, 2008 |
| First posted | Mar 7, 2007 |
| Last update posted | Aug 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: